Age-related androgen deficiency and type 2 diabetes

Journal of Pharmacy Practice

Volumn 24, Issue 3, 2011, Pages 316-322

  Ryan, Gina J ^a   Jobe, Lynetta J ^b  

^a MERCER UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

Author keywords

andropause; diabetes; hypogonadism; men's health; testosterone

Indexed keywords

ANDROID; CHORIONIC GONADOTROPIN; DELASTRYL; ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADORELIN ANTAGONIST; GONADOTROPIN ANTAGONIST; LUTEINIZING HORMONE; METHYLTESTOSTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG; WARFARIN;

ACNE; AGGRESSION; ANDROGEN DEFICIENCY; ARTICLE; BONE DENSITY; BREAST CANCER; BREAST TENDERNESS; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; ERYTHROCYTOSIS; GLUCOSE TOLERANCE; GUM IRRITATION; GYNECOMASTIA; HAIR LOSS; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INJECTION SITE PAIN; INSULIN SENSITIVITY; LIBIDO; LIVER TOXICITY; MALE INFERTILITY; METABOLIC SYNDROME X; MOOD CHANGE; MOUTH DISEASE; MUSCLE MASS; NIPPLE TENDERNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PHARMACIST; PROSTATE CANCER; PROSTATE HYPERTROPHY; SIDE EFFECT; SKIN IRRITATION; SLEEP APNEA SYNDROME; SPERMATOZOON COUNT; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 79958129611     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190010397719     Document Type: Article

References (42)

1. Petak SM, Nankin HR, Spark RF, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract. 2002 ; 8 (6). 440-456
2. Araujo A, O'Donnell A, Brambilla D, et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metabol. 2004 ; 89 (12). 5920-5926 (Pubitemid 39628393)
3. Harman S, Metter E, Tobin J, et al. Longitudinal effects of aging on serum total and free tesosteone levels in healthy men; Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001 ; 86 (2). 724-731 (Pubitemid 32207487)
4. Corona G, Mannucci E, Petrone L, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006 ; 18 (2). 190-197 (Pubitemid 43336487)
5. Dhindsa S, Prabhakar S, Sethi M, et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004 ; 89 (11). 5462-5468 (Pubitemid 39518427)
6. Rhoden EL, Ribeiro EP, Teloken C, et al. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int. 2005 ; 96 (6). 867-870 (Pubitemid 41391398)
7. Ganesh HK, Vijaya Sarathi HA, George J, et al. Prevalence of hypogonadism in patients with type 2 diabetes mellitus in an Asian Indian study group. Endocr Pract. 2009 ; 15 (6). 513-520
8. Kapoor D, Aldred H, Clark S, et al. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007 ; 30 (4). 911-917 (Pubitemid 46556586)
9. Diver MJ. Laboratory measurement of testosterone. Front Horm Res. 2009 ; 37: 21-31
10. de Ronde W, van der Schouw YT, Pierik FH, et al. Serum levels of sex hormone-binding globulin (SHBG) are not associated with lower levels of non-SHBG-bound testosterone in male newborns and healthy adult men. Clin Endocrinol (Oxf). 2005 ; 62 (4). 498-503
11. de Ronde W, van der Schouw YT, Pols HA, et al. Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin Chem. 2006 ; 52 (9). 1777-1784 (Pubitemid 44330714)
12. Giton F, Fiet J, Guechot J, et al. Serum bioavailable testosterone: assayed or calculated?. Clin Chem. 2006 ; 52 (3). 474-481
13. Ding EL, Song Y, Malik VS, et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006 ; 295 (11). 1288-1299
14. Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007 ; 30 (2). 234-238 (Pubitemid 46198324)
15. Oh JY, Barrett-Connor E, Wedick NM, et al. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002 ; 25 (1). 55-60 (Pubitemid 41070783)
16. Vermeulen A. Decreased androgen levels and obesity in men. Ann Med. 1996 ; 28 (1). 13-15 (Pubitemid 26056040)
17. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypoth. 2001 ; 56 (6). 702-708 (Pubitemid 32588221)
18. Plymate S, Matej L, Jones R, et al. Inhibition of sex hormone binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988 ; 67 (3). 460-464
19. Muller M, Grobbee DE, den Tonkelaar I, et al. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005 ; 90 (5). 2618-2623 (Pubitemid 40686299)
20. Vermeulen A, Kaufman JM, Deslypere JP, et al. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab. 1993 ; 76 (5). 1140-1146 (Pubitemid 23155426)
21. Barrett-Connor E, Khaw K, Yen S. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990 ; 132 (5). 895-901 (Pubitemid 20363668)
22. Chen RY, Wittert GA, Andrews GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab. 2006 ; 8 (4). 429-435 (Pubitemid 44349235)
23. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 ; 95 (6). 2536-2559
24. Morley JE, Charlton E, Patrick P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000 ; 49 (9). 1239-1242
25. Smith KW, Feldman HA, McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in aging men. Clin Endocrinol. 2000 ; 53 (6). 703-711 (Pubitemid 32096681)
26. Moore C, Huebler D, Zimmermann T, et al. The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol. 2004 ; 46 (1). 80-87 (Pubitemid 38748514)
27. Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002 ; 87 (1). 136-143 (Pubitemid 34084682)
28. Marin P, Krotkiewski M, Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med. 1992 ; 1 (6). 329-336
29. Corrales JJ, Burgo RM, Garca-Berrocal B, et al. Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism. 2004 ; 53 (5). 666-672 (Pubitemid 38596543)
30. Lee CH, Kuo SW, Hung YJ, et al. The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics. Endocr Res. 2005 ; 31 (2). 139-148
31. Gopal RA, Bothra N, Acharya SV, et al. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus. Endocr Pract. 2010 ; 16 (4). 570-576
32. Boyanov M, Boneva Z, Christov V. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003 ; 6 (1). 1-7 (Pubitemid 36606394)
33. Kapoor D, Goodwin E, Channer KS, et al. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006 ; 154 (6). 899-906 (Pubitemid 43997730)
34. Yialamas MA, Dwyer AA, Hanley E, et al. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007 ; 92 (11). 4254-4259 (Pubitemid 350074740)
35. Corona, CA: Watson Pharma ; 2005 :
36. Knuth UA, Honigl W, Bals-Pratsch M, et al. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab. 1987 ; 65 (6). 1081-1087 (Pubitemid 18026838)
37. Roth MY, Page ST, Lin K, et al. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. J Clin Endocrinol Metab. 2010 ; 95 (8). 3806-3813
38. Liu PY, Wishart SM, Handelsman DJ. A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2002 ; 87 (7). 3125-3135 (Pubitemid 34816354)
39. Meier C, Liu PY, Ly LP, et al. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency. J Clin Endocrinol Metab. 2004 ; 89 (6). 3033-3041 (Pubitemid 38766405)
40. Liu PY, Wishart SM, Celermajer DS, et al. Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. Eur J Endocrinol. 2003 ; 148 (1). 55-66 (Pubitemid 36176005)
41. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003 ; 51 (1). 101-115 (Pubitemid 36119943)
42. Covington, NJ: Columbia Laboratories ; 2003 :